It is a conference prepared for people who want to increase their knowledge in the field of risk assessment, innovation and valuation of biotechnology companies.

Panel I
Evaluation of the Company’s value – how to analyze data, documents and valuations of Companies
prof. Tadeusz Pietrucha, Bio-Tech Consulting Sp. z o. o.

Panel II
Assessment of the company’s potential in terms of innovation and product technology.
Robert Florczykowski PKO TFI (speaker did not consent to video recording)

A short analysis of companies listed on the Warsaw Stock Exchange and NEWCONNECT in terms of investments in BIOTECHNLOGY.
Grzegorz Zebrowski ARIA FUND

Discussion panel with Experts – Biotechnology companies listed on the Warsaw Stock Exchange and NewConnect – how to assess the potential, profitability rate and investment horizon, i.e. when we can expect profit. Participants of the event can ask questions.
representatives of the following companies: Biotts, BIOCELTIX, GENOMTEC